43 articles for thisTarget
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Data
Article Title
Organization
Combined Interactions with I

University of Camerino
A combined ligand- and structure-based approach for the identification of rilmenidine-derived compounds which synergize the antitumor effects of doxorubicin.

University of Belgrade
Transfer of SAR information from hypotensive indazole to indole derivatives acting ata-adrenergic receptors: In vitro and in vivo studies.

Medical University of Gdansk
Antagonism/Agonism modulation to build novel antihypertensives selectively triggering i1-imidazoline receptor activation.

University of Camerino
Synthesis and biological evaluation of 2-aryliminopyrrolidines as selective ligands for I1 imidazoline receptors: discovery of new sympatho-inhibitory hypotensive agents with potential beneficial effects in metabolic syndrome.

University of Strasbourg
Identification of small molecule inhibitors of amyloidß-induced neuronal apoptosis acting through the imidazoline I(2) receptor.

Imim-Hospital Del Mar Research Institute and University Pompeu Fabra
Methylation of imidazoline related compounds leads to loss ofa2-adrenoceptor affinity. Synthesis and biological evaluation of selective I1 imidazoline receptor ligands.

University of Strasburg
Discovery of N-{1-[3-(3-oxo-2,3-dihydrobenzo[1,4]oxazin-4-yl)propyl]piperidin-4-yl}-2-phenylacetamide (Lu AE51090): an allosteric muscarinic M1 receptor agonist with unprecedented selectivity and procognitive potential.

H. Lundbeck
QSAR study of imidazoline antihypertensive drugs.

University of Belgrade
Designed multiple ligands. An emerging drug discovery paradigm.

Organon Laboratories
Synthesis and pharmacologic evaluation of 2-endo-amino-3-exo-isopropylbicyclo[2.2.1]heptane: a potent imidazoline1 receptor specific agent.

Allergan
Alpha- and beta-adrenoceptors: from the gene to the clinic. 2. Structure-activity relationships and therapeutic applications.

Smithkline Beecham Pharmaceuticals
Synthesis and biological activities of 2-[(heteroaryl)methyl]imidazolines.

Medical University of Gdansk
New imidazoline/a(2)-adrenoceptors affecting compounds-4(5)-(2-aminoethyl)imidazoline (dihydrohistamine) derivatives. Synthesis and receptor affinity studies.

Gdansk University of Technology
3-[(Imidazolidin-2-yl)imino]indazole ligands with selectivity for thea(2)-adrenoceptor compared to the imidazoline I(1) receptor.

Medical University of Gdansk
New analogues of agmatine with higher affinity to imidazoline receptors.

Gda£?Sk University of Technology
Novel ligands rationally designed for characterizing I2-imidazoline binding sites nature and functions.

Università
1-[(Imidazolidin-2-yl)imino]indazole. Highly alpha 2/I1 selective agonist: synthesis, X-ray structure, and biological activity.

Medical University of Gda£?Sk
Binding of beta-carbolines at imidazoline I2 receptors: a structure-affinity investigation.

Virginia Commonwealth University
Binding of an imidazopyridoindole at imidazoline I2 receptors.

Virginia Commonwealth University
Binding of beta-carbolines at 5-HT(2) serotonin receptors.

Virginia Commonwealth University
Synthesis and biological evaluation of new 2-(4,5-dihydro-1H-imidazol-2-yl)-3,4-dihydro-2H-1,4-benzoxazine derivatives.

Université
Probes for imidazoline binding sites: synthesis and evaluation of a selective, irreversible I2 ligand.

University of Bristol
Bicyclic α-Iminophosphonates as High Affinity Imidazoline I

University of Barcelona
Fluorinated analogues of marsanidine, a highly α2-AR/imidazoline I1 binding site-selective hypotensive agent. Synthesis and biological activities.

Medical University of Gdansk
Development of high-affinity 5-HT3 receptor antagonists. Structure-affinity relationships of novel 1,7-annelated indole derivatives.

Solvay Duphar
alpha 2-adrenoreceptors profile modulation. 2. Biphenyline analogues as tools for selective activation of the alpha 2C-subtype.

University of Camerino
Imidazoline binding sites (IBS) profile modulation: key role of the bridge in determining I1-IBS or I2-IBS selectivity within a series of 2-phenoxymethylimidazoline analogues.

University of Camerino
Synthesis and biological evaluation of pyrrolinic isosteres of rilmenidine. Discovery of cis-/trans-dicyclopropylmethyl-(4,5-dimethyl-4,5-dihydro-3H-pyrrol-2-yl)-amine (LNP 509), an I1 imidazoline receptor selective ligand with hypotensive activity.

Louis Pasteur University
3D-QSAR CoMFA study on imidazolinergic I(2) ligands: a significant model through a combined exploration of structural diversity and methodology.

Orleans University
2-(2-Phenylcyclopropyl)imidazolines: reversed enantioselective interaction at I(1) and I(2) imidazoline receptors.

University of Camerino
SPIROCYCLIC MODULATORS OF CHOLESTEROL BIOSYNTHESIS AND THEIR USE FOR PROMOTING REMYELINATION

Genentech
Substituted [1,2,4]triazolo[4,3-a]pyrazines as BRD4 inhibitors

Boehringer Ingelheim International
Serotonin receptor modulators

Janssen Pharmaceutica
Heteroaromatic compounds as BTK inhibitors

Boehringer Ingelheim International
CXCR2 inhibitors

Sanofi
Identification of RIP1 kinase as a specific cellular target of necrostatins.

Tufts University
Correlating solution binding and ESI-MS stabilities by incorporating solvation effects in a confined cucurbit[8]uril system.

University of Cambridge
Rigid duplex alpha-cyclodextrin reversibly connected with disulfide bonds. Synthesis and inclusion complexes.

Institute of Organic Chemistry and Biochemistry As Cr
Discovery of begacestat, a Notch-1-sparing gamma-secretase inhibitor for the treatment of Alzheimer's disease.

Wyeth Research